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Summary
The proto-oncogene Src tyrosine kinase (Src) is overexpressed in human cancers and is currently a target of anti-invasive therapies.
Activation of Src is an essential catalyst of invadopodia production. Invadopodia are cellular structures that mediate extracellular
matrix (ECM) proteolysis, allowing invasive cell types to breach confining tissue barriers. Invadopodia assembly and maturation is a
multistep process, first requiring the targeting of actin-associated proteins to form pre-invadopodia, which subsequently mature by
recruitment and activation of matrix metalloproteases (MMPs) that facilitate ECM degradation. We demonstrate that active, oncogenic
Src alleles require the presence of a wild-type counterpart to induce ECM degradation at invadopodia sites. In addition, we identify
the phosphorylation of the invadopodia regulatory protein cortactin as an important mediator of invadopodia maturation downstream
of wild-type Src. Distinct phosphotyrosine-based protein-binding profiles in cells forming pre-invadopodia and mature invadopodia
were identified by SH2-domain array analysis. These results indicate that although elevated Src kinase activity is required to target
actin-associated proteins to pre-invadopodia, regulated Src activity is required for invadopodia maturation and matrix degradation
activity. Our findings describe a previously unappreciated role for proto-oncogenic Src in enabling the invasive activity of constitutively
active Src alleles.
Key words: Head and Neck cancer, Src, Invadopodia, Cortactin

Introduction
Src is the first described proto-oncogene and a current target for
anti-invasive compounds in clinical trials (Brunton and Frame,
2008; Yeatman, 2004). Src participates in a vast array of cellular
functions that include the regulation of cell proliferation, adhesion,
migration and invasion (Guarino, 2010; Thomas and Brugge, 1997).
In normal cells, Src activity is tightly controlled through
intramolecular regulation, subcellular localization and protein
expression levels. Elevated or aberrant Src activity is a potent
mediator of cell transformation and tumor progression, and is
associated with the majority of human cancers including head and
neck squamous cell carcinoma (HNSCC) (Summy and Gallick,
2003).
One of the most evident phenotypes of Src-transformed cells is
the formation of actin-rich ventral membrane protrusive structures
that actively degrade ECM (Chen, 1989). These structures, termed
invadopodia, are made by metastatic cancer cells and Srctransformed fibroblasts (Linder, 2009). Invadopodia spontaneously
form in tumor cells directly cultured from patient samples and are
hypothesized to facilitate breaching of basement membranes during
metastasis (Clark et al., 2007; Yamaguchi and Condeelis, 2007).
Src activity is absolutely necessary for invadopodia formation and
function, and the level of tyrosine phosphorylation at invadopodia
positively correlates with the degree of ECM degradation (Bowden
et al., 2006; Spinardi et al., 2004). The molecular components that
make up invadopodia include proteins that facilitate actin assembly,
membrane trafficking and focal degradation. Src substrates
participate in all of these functions and include the proteins cortactin

(Bowden et al., 1999), N-WASp (Yamaguchi et al., 2005), dynamin2 (Baldassarre et al., 2003), AMAP1 (Onodera et al., 2005), paxillin
(Bowden et al., 1999), p130Cas (Brabek et al., 2004), Tsk5 (Seals
et al., 2005), p190RhoGAP (Nakahara et al., 1998), AFAP110
(Gatesman et al., 2004) and caveolin (Yamaguchi et al., 2009).
Several studies have evaluated Src activity in invadopodia
formation through the ectopic expression of constitutively active
Src alleles (Artym et al., 2006; Oser et al., 2009; Stylli et al.,
2009). However, these activating Src mutants are rarely found in
human tumors, which instead typically contain increased levels of
wild-type (WT) Src expression and/or aberrant WT Src activity
due to hyperactivation of upstream pathways (Yeatman, 2004).
The role of WT Src in invadopodia formation and function is
unknown.
Invadopodia assembly has been proposed to involve several
stages that regulate the progression from pre-invadopodia (nondegradative) complexes to functional, mature invadopodia
containing active MMPs that degrade ECM (Artym et al., 2006;
Oser et al., 2009). In current models of invadopodia formation,
filamentous (F)-actin and the actin-associated protein cortactin are
recruited to sites of matrix adhesion, resulting in pre-invadopodia
complexes (Artym et al., 2006). The membrane-bound matrix
metalloproteinase MT1-MMP (MMP14) is subsequently recruited
to these sites, allowing matrix degradation and invadopodia
maturation. Cortactin is an actin-binding protein that is
phosphorylated by Src kinase (Head et al., 2003), and is a core
invadopodia component. Knockdown of cortactin expression results
in decreased invadopodia formation (Artym et al., 2006; Webb et
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al., 2007) and MMP secretion (Clark and Weaver, 2008; Clark et
al., 2007), whereas phosphorylation of cortactin is important for
regulation of matrix degradation at invadopodia (Ayala et al.,
2008).
Recent work on discerning the molecular mechanism regulating
actin polymerization before MMP recruitment has identified
dynamic regulation of cortactin phosphorylation or
dephophorylation downstream of Src to be central to this process
(Oser et al., 2009). In this model, cortactin sequesters the actinsevering protein cofilin within pre-invadopodia. Tyrosine
phosphorylation of cortactin releases cofilin, which in turn
accelerates actin polymerization by severing existing invadopodial
actin filaments. In addition, tyrosine phosphorylation of cortactin
creates docking sites for the adaptor protein Nck1, which binds
and activates the Arp2/3 activator N-WASp. The combined effect
of cofilin activation and N-WASp-mediated Arp2/3 activity serves
to increase actin polymerization as pre-invadopodia mature and
obtain the ability to degrade ECM. Dephosphorylation of cortactin
is proposed to stabilize maturing invadopodia by downregulating
actin polymerization through liberation of the Nck1–N-WASp
complex, coupled with rebinding of inactive cofilin. Although
these data implicate cycles of cortactin phosphorylation and
dephosphorylation as crucial in invadopodia maturation, it is not
known how the phosphorylation of cortactin and other invadopodia
maturation-associated proteins is spatially and temporally
orchestrated through upstream kinase-based signaling to drive
invadopodia maturation. In this study, we have determined that the
presence of endogenous, regulated WT c-Src is required for the
maturation of pre-invadopodia complexes induced by oncogenic
Src activity into degradative invadopodia. In addition, we show
that cortactin phosphorylation downstream of WT c-Src is an
important mediator of the maturation process.
Results
Elevated Src activity regulates invadopodia formation in
HNSCC cell lines

The introduction of constitutively active viral Src (v-Src) or
constitutively active cellular Src (Src527F) has been examined in
invadopodia formation in cancer cell lines (Artym et al., 2006;
Buschman et al., 2009; Oikawa et al., 2008; Stylli et al., 2009), but

the role of endogenous c-Src in invadopodia function is unclear. We
analyzed a panel of HNSCC lines for endogenous c-Src activity and
total c-Src protein levels (Fig. 1A), as well as the ability of these
lines to form spontaneous invadopodia on FITC-gelatin matrix (Fig.
1B; supplementary material Fig. S1A). Two (UMSCC1 and OSC19)
out of the six tested lines generate invadopodia that were identified
by the colocalization of actin and cortactin-rich yellow aggregates in
merged images (Fig. 1B, white arrows) coinciding with areas of
focal gelatin degradation (black arrows). UMSCC1 and OSC19 cells
had substantially elevated c-Src expression and c-Src activity
compared with the UMSCC2, 1483 and MSK921 cell lines that do
not make invadopodia (Fig. 1A). The FADU cells had elevated c-Src
activity, but failed to generate spontaneous invadopodia, suggesting
that elevated Src expression alone is not sufficient to drive
invadopodia biogenesis in this line. However, invadopodia are formed
and matrix degradation occurs in all the HNSCC cell lines that do
not form spontaneous invadopodia (UMSCC2, 1483, FADU and
MSK921) following exogenous Src527F expression (Fig. 1B;
supplementary material Fig. S1B). These data suggest a cell-linespecific threshold of Src activity (highest in FADU cells) that must
be reached to support invadopodia formation and matrix degradation.
These results are consistent with the idea that elevated Src activity
drives invadopodia biogenesis, and are in agreement with previous
work with small-molecule Src inhibitors in HNSCC cell lines, which
found a dose-dependent decrease of invadopodia formation and
matrix degradation (Ammer et al., 2009). Similar results have also
been shown for breast cancer cells (Pichot et al., 2009).
Endogenous Src expression is required for efficient
invadopodia-based matrix degradation in HNSCC cells
expressing constitutively active Src

To test the effect of depletion of endogenous c-Src on HNSCC
invadopodia formation and function, c-Src expression was knocked
down in UMSCC1 cells by RNA interference (SrcSi) (Fig. 2A)
and assayed for invadopodia formation and gelatin degradation
(Fig. 2B). Endogenous c-Src was depleted by 58% at 2 days, and
by 70% at 3 days after transfection. Src-knockdown cells had no
statistically significant difference in the number of cells with
invadopodia or the number of invadopodia per cell (Fig. 2C, top
and middle panels). However, SrcSi cells exhibited a 57% decrease

Fig. 1. Src activity regulates invadopodia formation in HNSCC lines. (A)Protein levels of active c-Src (Src-pY418), total c-Src (Src) and -actin (loading
control) in HNSCC lines. For quantification of active Src and total Src, expression levels were normalized to MSK921 cells, a line with low Src activity that does
not form invadopodia. The multiple bands in the Src-pY418 panel presumably represent additional Src Family kinases; see Fig. 3A. (B)HNSCC cell lines with or
without Src-527F were incubated on FITC-gelatin (pseudocolored white) coverslips for 12 hours and labeled with TRITC–phalloidin (red) and anti-cortactin
(green). Invadopodia are identified by the yellow aggregates in the merged images of actin and cortactin (white arrows) that localize with the dark holes in the
FITC-gelatin (black arrows). Scale bars: 10m.
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Fig. 2. Inhibition of endogenous Src expression
decreases matrix degradation independently of changes
in invadopodia number or increased Src activity.
(A)UMSCC1 cells transfected with siRNA directed
against Src (SrcSi) or a non-targeting siRNA (Ctl) were
evaluated for Src knockdown 2 and 3 days after
transfection by anti-Src western blotting. -actin blotting
was used as a loading control. (B)Cell lysates from
UMSCC1 cells transfected with non-targeting siRNA (Ctl)
or SRC siRNA (SrcSi) alone, or in combination with
cerulean-tagged SrcWT (WT) or Src-527F (527) were
evaluated by immunoblotting. Lysates were probed with
anti-Src and anti--actin antibodies. Filled arrowhead
indicates exogenously expressed Src (WT or 527F), open
arrowhead denotes endogenous Src. (C) Representative
confocal images of UMSCC1 cells transfected with nontargeting siRNA (Ctl) or SrcSi alone, or in combination
with cerulean-tagged SrcWT (WT) or Src-527F (527).
Cells were plated on FITC-gelatin-coated (pseudocolored
white) coverslips for 10 hours and immunolabeled with
TRITC–phalloidin (red) and cortactin (green). Scale bars:
10m. (D)Percentage of cells displaying invadopodia
(top), the number of invadopodia per cell (middle) and the
amount of matrix degradation per cell (bottom) were
examined for each line evaluated in B. Data are presented
as mean ± s.e.m.; #, statistically different from control
(P≤0.01); groups under the bar are statistically different
(P<0.01).

in gelatin degradation compared with control cells (Ctl) (Fig. 2C,
bottom panel). Rescue of WT Src expression in SrcSi cells
(SrcSi+WT) restored matrix degradation to levels above those of
the control cells (1.7-fold) (Fig. 2C). Increases above control levels
are presumably due to the additive effect of remaining endogenous
Src from incomplete knockdown coupled with the modest
overexpression of the WT Src construct (Fig. 2B).
We also examined the effect of silencing endogenous c-Src in
the presence of constitutively active Src (Fig. 2B,C). Consistently
with previous reports (Artym et al., 2006; Oser et al., 2009),
expression of Src527F in control cells (Ctl+527) or SrcSi cells
(SrcSi+527F) resulted in increases in the number of cells with
invadopodia (~30%) and the number invadopodia per cell (~36%).
Surprisingly, c-Src knockdown markedly blunted the increased
degradation due to Src527F expression, a 2.5-fold (SrcSi+Src527F
cells) increase compared with a 4.8-fold (Ctl+527F) increase over
control cells (Fig. 2C). These results demonstrate that constitutively
active Src cannot completely rescue the role of endogenous c-Src
in regulation of matrix degradation. Collectively, these data indicate
that although increased Src activity enhances invadopodia
formation, the presence of endogenous c-Src is required for optimal
matrix degradation. Similar results were found in OSC19 cells
(supplementary material Fig. S2).

Constitutively active Src is sufficient to promote
invadopodia formation but not ECM degradation in Srcnull cells

Complete c-Src knockdown in our HNSCC lines is technically
problematic because additional Src family kinases (Yes and Fyn)
with unknown functions in invadopodia biology are present and
maintained in OSC19 and UMSCC1 cell lines treated with SrcSi
(Fig. 3A). We therefore used Src-, Yes- and Fyn-deficient (SYF)
fibroblasts to further evaluate the role of WT Src in invadopodia
function. A GFP-tagged temperature-sensitive mutant of v-Src
(tsLa29–GFP) was generated and expressed in SYF cells to
dynamically regulate Src activity and invadopodia formation. Src
kinase activation occurs within 15 minutes when cells are switched
from the non-permissive temperature (41°C) to the permissive
temperature (35°C) (Fig. 3B). v-Src inactivation occurs within 30
minutes when cells are shifted back to 41°C. Activation of v-Src
leads to the phosphorylation of cortactin on Tyr421, indicating that
tsLa29–GFP regulates phosphorylation of a known downstream
Src target that is crucial for invadopodia assembly. In agreement
with previous reports (Walker et al., 2007), invadopodia formation
is induced when cells expressing tsLa29–GFP are switched to the
permissive temperature (Fig. 3C). These invadopodia are enriched
with active v-Src and phosphorylated cortactin (Fig. 3C;
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Fig. 3. Invadopodia produced by constitutively active Src in SYF fibroblasts fail to degrade ECM. (A)Src family kinase expression in HNSCC and fibroblast
cell lines. Clarified cell lysates from SYF, SYF+/+, UMSCC1 (treated with control and SrcSi), and OSC19 (expressing control vector and SRC shRNA) cells were
resolved by SDS-PAGE and immunoblotted with anti-Src, anti-Yes, anti-Fyn and anti--actin antibodies. (B)Time course of tsLa29 v-Src activation and resulting
cortactin phosphorylation. Cells transfected with tsLa29 were incubated at 35°C (permissive temperature) for the indicated times and were lysed or returned to
41°C (non-permissive temperature) for 15 or 30 minutes and analyzed for Src-pY418, GFP, cortactin, and cortactin-pY421. (C)Invadopodia formation in cells
expressing v-Src. SYF cells were transfected with tsLa29–GFP (pseudocolored light blue) and incubated at 41°C or 35°C and labeled with TRITC–phalloidin (red)
and cortactin (green). Cells were visualized by confocal microscopy and z-stack sectioning. Invadopodia are visible in z-stack images as actin- and cortactin-rich
puncta that are several micrometers in length (white arrows). Scale bars: 10m, 5m (z-stacks). (D)Defective ECM degradation in SYF cells expressing v-Src.
SYF cells transfected with tsLa29-v-Src and non-transfected UMSCC1 cells (positive control) were plated directly onto FITC-gelatin-coated coverslips. After 24
hours, cells were labeled with TRITC–phalloidin and anti-cortactin antibodies. White arrows indicate invadopodia and black arrows, areas of degraded matrix in C
and D. Scale bars: 10m.

supplementary material Fig. S3A). As reported in other
invadopodia-forming cell systems (Artym et al., 2006; Ayala et al.,
2008; Clark et al., 2007; Webb et al., 2006), inhibition of cortactin
expression using siRNA diminishes the ability of tsLa29–GFP to
induce invadopodia formation at the permissive temperature
(supplementary material Fig. S3B,C).
To evaluate the functionality of invadopodia in this system, we
plated SYF cells on FITC-gelatin-coated coverslips to assay ECM
degradation. Invadopodia induced by tsLa29–GFP in the Src-null
fibroblasts fail to degrade the ECM at periods up to and beyond 48
hours, indicating they remain in a pre-invadopodia state (Fig. 3D).
Experiments with an untagged v-Src produced a similar result,
ruling out improper activation or localization related to the addition
of GFP. We also attempted to rescue invadopodia maturation in the
SYF cells with tsLa29 v-Src. Manipulation of tsLa29 v-Src activity
over the 24 hour incubation period by switching cells from
permissive to the non-permissive temperatures did not result in
invadopodia maturation (data not shown). These results demonstrate
that constitutively active v-Src activity is responsible for the
induction of the initial phosphorylation cascade that drives
recruitment of invadopodia components to form pre-invadopodia
complexes, but these v-Src-induced complexes are insufficient to
direct matrix degradation in SYF cells.
Wild-type Src kinase is necessary for invadopodia
maturation

Based on our findings we hypothesized that either: (1) another
ubiquitously expressed Src family kinase (Yes and/or Fyn) absent
from SYF cells is required for invadopodia maturation in addition
to active Src, or (2) WT Src or ‘regulated’ Src must also be present
with active Src for degradation of ECM to occur. To test these
hypotheses, we used a SYF cell line with two copies of WT Src

genetically reintroduced to restore normal WT Src expression
(SYF+/+; Fig. 3A, Fig. 4A). The percentage of cells forming
invadopodia and the percentage of invadopodia-forming cells
degrading matrix were assessed following introduction of v-Src or
Src527F. Transfection with activated Src constructs in the form of
tsLa29 or Src527F induces mature matrix-degrading invadopodia
in SYF+/+ cells, in contrast to pre-invadopodia formation in SYF
cells (Fig. 4B). Approximately 55% of SYF+/+ cells forming
invadopodia contained invadopodia that actively degraded matrix,
compared with 2% of SYF cells (Fig. 4C). There was no difference
in the percentage of cells forming invadopodia (pre and mature) in
SYF or SYF+/+ cells expressing Src527F (Fig. 4C), which is similar
to results in UMSCC1 cells (Fig. 2C). Also, the level of general
phosphotyrosine-containing proteins localized to invadopodia was
unchanged in SYF527F and SYF527F+/+ cells (Fig. 4B). Taken
together, these results suggest that catalytically active Src alone
promotes the assembly of pre-invadopodia complexes and targets
tyrosine phosphorylation of proteins within these structures, but
SrcWT is necessary for pre-invadopodia maturation required to
induce ECM degradation.
To confirm these findings, WT Src expression was transiently
restored in SYF cells and assayed for ECM degradation. Monitoring
of the coexpression of Src527F and SrcWT was achieved by
creating C-terminal linker fusions with mCherry (Src527F–
mCherry) and cerulean (Src–Cer) fluorescent proteins
(supplementary material Fig. S4). Transfection efficiency of the
co-transfected Src constructs was consistently greater than 90%
and imaging revealed that nearly all SYF cells expressed both Src
alleles (supplementary material Fig. S5A). In SYF cells expressing
SrcWT alone, Src had a perinuclear localization that was consistent
with previous reports (Sandilands et al., 2004) (supplementary
material Fig. S4B,C). Coexpression of Src527F with WT Src
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Fig. 4. WT Src rescues invadopodia maturation in cells expressing constitutively active Src. (A)SYF, SYF+/+ and UMSCC1 cells that were non-transfected
(NT), transfected with Src-527F or ts-v-Src, were lysed, resolved by SDS-PAGE and immunoblotted with anti-Src-pY418, anti-Src clone EC10 (only recognizes
avian Src), anti-cortactin-pY421, anti-cortactin (4F11), and anti--actin antibodies. (B)SYF, SYF+/+ and UMSCC1 cells that were non-transfected (NT), transfected
with SRC-527F, or tsLa29-v-Src were plated onto FITC-conjugated gelatin coverslips and evaluated by confocal microscopy. Cells were labeled with TRITC–
phalloidin (red), cortactin (green), and anti-phosphotyrosine (light blue) antibodies. Invadopodia are identified by the yellow aggregates in the merged image of
actin and cortactin in cells containing phosphotyrosine. In addition, degrading (mature) invadopodia localize with the dark holes (arrows) in the FITC-gelatin
(white). (C)Quantification of the percentage of cells forming invadopodia structures (actin and cortactin aggregates, left), and the percentage of invadopodiaforming cells that contain matrix degradation (mature invadopodia, right). Data are represented as mean ± s.d.; *P≤0.05.

results in recruitment of WT Src to invadopodia where it colocalizes
with Src527F (Fig. 5A). In addition, cells coexpressing these
constructs regain the ability to degrade ECM (Fig. 5B,C). To
further verify the functional requirement for WT Src in invadopodia
maturation, we conducted WT-Src-specific staining of SYF cells
containing Src527F. WT Src colocalizes with cortactin to areas of
ECM degradation, further demonstrating that Src localizes to
mature invadopodia (Fig. 5D, top panels). In addition, direct
visualization of WT Src–Cer and Src527F–mCherry in SYF cells
demonstrates a concentration of Src–Cer at areas of ECM
degradation, with Src527F–mCh localized to the same vicinity
(Fig. 5D, bottom panels).
Since the localization of endogenous Src to invadopodia is
required for invadopodia maturation, we determined whether
catalytically inactive Src could substitute for WT Src and rescue
ECM degradation in SYF cells. This result would suggest that two
separate and distinct pools of Src (constitutively active and kinaseinactive) are necessary and sufficient for maturation. To test this
hypothesis, constitutively active Src527F–mCherry was
coexpressed with a cerulean-tagged kinase-inactive Src (Src295M–
Cer) in SYF cells. Similarly to WT Src, Src295M was largely
perinuclear when expressed alone in SYF cells (supplementary
material Fig. S4B,C), but was recruited to invadopodia when
coexpressed with Src527F (Fig. 5A). However, Src295M failed to
rescue invadopodia maturation (Fig. 5B,C), indicating that
catalytically inactive Src does not substitute for WT Src function.
Since constitutively active and kinase-dead Src cannot support

invadopodia maturation, this suggests that WT Src kinase activity
is dynamically regulated to promote invadopodia maturation.
Similarly, cell staining for active Src (pY418) localized to preinvadopodia in SYF cells and mature invadopodia in SYF+/+ cells
(Fig. 5E), ruling out the possibility that catalytically active Src
initially drives invadopodia assembly, then is inactivated and
remains inactive during maturation. Taken together, these results
demonstrate that regulated WT Src kinase activation and
inactivation within pre-invadopodia complexes is necessary to
govern the downstream signaling events required for invadopodia
maturation and ECM degradation.
Regulated Src activity directs cortactin phosphorylation
dynamics to control invadopodia maturation

In proposed models of invadopodia maturation, dynamic cortactin
tyrosine phosphorylation is required for pre-invadopodia maturation
(Oser et al., 2009). To identify a potential mechanism of
invadopodia maturation affected by regulated Src activation
and inactivation, we assessed the role of Src kinase activity on
cortactin phosphorylation. In the SYF/SYF+/+ system, cortactin
phosphorylated on Tyr421 localized to pre-invadopodia and mature
invadopodia (Fig. 6A), suggesting that cortactin phosphorylation
is important in pre-invadopodia assembly and invadopodia
maturation. This is consistent with a well-described role for
cortactin in invadopodia maturation in other systems (Artym et al.,
2006; Clark et al., 2007; Oser et al., 2009). Stable cell lines were
generated expressing endogenous levels of WT cortactin (control)
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Fig. 5. Expression of regulated Src is necessary for ECM degradation at invadopodia. (A)Confocal imaging of SYF cells coexpressing Src–Cerulean and
Src527F–mCherry, or Src-295M–Cerulean and Src527F–mCherry. Cells were immunolabeled with anti-cortactin and Alexa-Flour-647-labeled phalloidin. Dashed
boxes represent enlarged image regions shown below. Arrows denote invadopodia. (B)Representative fields of SYF and SYF+/+ cells expressing Src527F–
mCherry, SYF cells coexpressing Src527F–mCherry and Src–Cerulean, or SYF cells coexpressing Src527F–mCherry and Src295M–Cerulean. Cells were plated
on FITC-gelatin-coated coverslips for 24 hours and immunolabeled with anti-cortactin. Areas of gelatin degradation and clearing appear black against the
pseudocolored white background. (C)Percentage of cells with forming invadopodia (actin and cortactin aggregates, left), and percentage of invadopodia-forming
cells with degraded matrix (mature invadopodia, right) from the experimental conditions shown in B. Data are represented as mean ± s.d.; *P≤0.05. (D)Confocal
imaging (top) or swept-field imaging (bottom) of SYF cells coexpressing c-Src527F and Src–Cerulean. Cells were plated on FITC-gelatin-coated coverslips and
immunolabeled with anti-cerulean (dark blue) and anti-cortactin (yellow) (colocalization appears white in merged image; top panel) or directly imaged for
Src527F–mCherry (red) and Src–Cerulean (dark blue) (bottom panels). Arrow indicates colocalization of Src 527F–mCherry and WT Src–Cerulean at sites of
gelatin degradation. (E)Confocal imaging of Src activity in SYF and SYF+/+ cells expressing Src527F. Cells were incubated on FITC-gelatin-coated coverslips for
24 hours, fixed and immunolabeled with TRITC–phalloidin (red), anti-pY418 Src (light blue) and anti-Src (green) antibodies. White arrows denote invadopodia;
black arrows, matrix degradation. Scale bars: 20m (B), 10m (A,D,E).

or a cortactin mutant in which the three Src-targeted tyrosine
residues (421, 470, 486) are mutated to phenylalanine (SYF+/+
CortTYM) (Fig. 6B). Endogenous murine cortactin was silenced
with siRNA (CortSi, knockdown >90%), resulting in the exclusive
expression of WT or mutant human cortactin (Fig. 6C). Wild-type
control and CortTYM SYF+/+ cell lines treated with siRNA to
knock down cortactin were transfected with Src527F to promote
invadopodia formation. Expression of WT human cortactin rescued
the inhibitory effects of cortactin knockdown on invadopodia
formation, resulting in the formation of mature invadopodia (~60%
of total cells with invadopodia, Fig. 6D,E). However, only ~10%
of SYF+/+ CortTYM cells produced degrading invadopodia.
Consistent with previous reports (Oser et al., 2009), there were no
differences observed in the percentage of cells forming actin or
cortactin aggregates in control and CortTYM SYF+/+ cells,
demonstrating that cortactin is targeted to pre-invadopodia

independently of tyrosine phosphorylation. However, expression
of mutant cortactin in SYF+/+ cells completely blocked the upstream
function of WT Src, rendering the SYF+/+ Src527F cells with a
degradation profile that was similar to that seen in cells lacking
WT Src (SYF Src527F, Fig. 4B,C). These results indicate that
there is differential phosphotyrosine signaling in SYF cells with
WT Src that supports invadopodia maturation downstream of
constitutively active Src.
Cells forming pre- and mature invadopodia have distinct
phosphotyrosine signatures

To examine whether distinct tyrosine phosphorylation signatures
occur in cells that form pre-invadopodia and mature invadopodia,
we conducted a non-biased, comprehensive and quantitative SH2domain screen (Machida et al., 2007) to identify differences in
potential phosphotyrosine-binding proteins under conditions of
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Fig. 6. WT Src regulates cortactin phosphorylation during invadopodia maturation. (A)SYF and SYF+/+ cells expressing Src527F were incubated on FITCgelatin-coated coverslips for 24 hours, fixed and immunolabeled with TRITC–phalloidin (red), human anti-pY421 cortactin (light blue) and anti-cortactin (green)
antibodies. Note that cortactin is phosphorylated in pre-invadopodia and in mature invadopodia, as defined by the absence or presence of matrix degradation.
(B)Validation of GFP-tagged cortactin expression in stable cell lines. Cellular extracts from SYF or SYF+/+ cells stably expressing GFP–CortWT or GFP–
CortTYM were resolved by SDS-PAGE and immunoblotted with an anti-cortactin (4F11) antibody. *, endogenous cortactin; **, GFP-tagged cortactin (the slight
mobility disparity is due to the size difference in AcGFP and EGFP tags); ratios of exogenous (WT and TYM) to endogenous cortactin is depicted under the blot.
(C)Clarified lysates from SYF+/+ GFP–CortWT and SYF+/+ GFP–CortTYM cells were transfected with Cttn siRNA alone or in combination with Src527F.
Cortactin was immunoprecipitated with the anti-cortactin (4F11) antibody, immunocomplexes resolved by SDS-PAGE and immunoblotted with human anti-pY421
cortactin and anti-cortactin (4F11) antibodies. Total cell lysates were immunoblotted with anti--actin as a loading control. (D)SYF+/+ cells stably expressing
human GFP–CortWT or GFP–Cort TYM were transfected with murine cortactin-targeted siRNA to eliminate endogenous cortactin expression. Two days later cells
were transfected with Src527F and plated on FITC-gelatin-coated coverslips for 24 hours to promote gelatin degradation. (E)Cells were assessed for the
percentage of cells forming invadopodia (actin and cortactin aggregates) and the percentage of invadopodia-forming cells with matrix degradation. Data are
represented as mean ± s.d., *P<0.05. Scale bars: 10m (A), 20m (B).

pre-invadopodia and mature invadopodia formation (Fig. 7;
supplementary material Fig. S6). Non-transfected SYF and SYF+/+
cells had minimal differences in SH2-domain binding profiles.
Expression of Src527F in either cell type enhanced overall SH2
domain signal-binding intensity, indicating a broad increase in
phosphotyrosine signaling and creation of new SH2-domain
docking sites. This result was anticipated with expression of
constitutively active Src. However, cells that form pre-invadopodia
(SYF Src527F) had distinct differences in their SH2 binding
intensity from cells that form functional mature invadopodia
(SYF+/+ Src527F) (bottom row, difference). The variations in
binding intensity that arise in SYF and SYF+/+ cells expressing
Src527F indicate a fundamental mechanistic difference in the
concentration of phosphotyrosine binding sites for several SH2domain-containing proteins that are likely to have key roles in
invadopodia maturation. Interestingly, tyrosine-phosphorylated
cortactin is known to interact with several high-intensity ‘hits’,
including Arg, Abl (Boyle et al., 2007), Fer (El Sayegh et al.,
2005), Crk (Bougneres et al., 2004) and Nck (Tehrani et al., 2007),
consistent with its role in invadopodia maturation. Experiments to
elucidate additional proteins involved in these signaling complexes
are currently underway.
Discussion
In this study, we investigated the role of endogenous or WT c-Src,
and the interplay between constitutively active Src and cellular Src
in invadopodia formation. Previous studies on Src in invadopodia

formation have exclusively manipulated Src activity in cells
containing WT c-Src. Tumor cells that form spontaneous
invadopodia presumably have upstream oncogenic signals such as
overactivation or overexpression of epidermal growth factor
receptor (EGFR), which drives c-Src activation (Xue et al., 2006).
Accordingly, increased Src kinase activity (through overexpression
of constitutively active Src, or overexpression of WT Src) in tumor
cells that form spontaneous invadopodia is associated with
increased invadopodia formation and matrix degradation (Artym
et al., 2006; Oser et al., 2009). Unlike previous reports (Oser et al.,
2009), we did not find that tumor cells overexpressing constitutively
active Src had less degradation per invadopodia than spontaneous
invadopodia formed in control cells (Fig. 2; supplementary material
Fig. S2). However, these differences might be attributed to a much
larger capacity for invadopodia formation in UMSCC1/OSC19
cells compared with MtLn3 cells (~25 vs ~two invadopodia formed
in control cells, respectively). In HNSCC cells and Src-null
fibroblasts, we propose that constitutively active Src acts as an
oncogenic ‘trigger’ that promotes pre-invadopodia formation,
whereas WT Src acts downstream to direct invadopodia stability
and maturation. Although models of spontaneous invadopodia
formation are invaluable to the field, our finding that Src cycling
is essential for invadopodia maturation could only be completely
uncovered through the use of the SYF/SYF+/+ system.
In this study, we show that WT Src is indispensable for
invadopodia maturation driven by elevated Src activity. We
hypothesize that distinct, temporally and spatially regulated Src
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Fig. 7. Enhanced binding of SH2 domains binding in
SYF+/+ cells expressing Src527F. In vitro SH2 and PTB
domain-binding profiles for SYF, SYF+/+ cells, and SYF and
SYF+/+ cells expressing Src527F. Binding of SH2 or PTB
domains to cell lysates are shown as a heat map where
intensity of red indicates strength of binding. Domain names
are on the top row, with a rank order of binding to SYF+/+
Src527F to denote potential importance in invadopodia
maturation. Sample labels are on the left side.
DifferenceSignal[SYF+/+ Src527F]–Signal[SYF Src527F].

function is necessary to regulate the phosphorylation of cortactin.
It is likely that Src regulates other scaffolding proteins that are
important in invadopodia stability and maturation, such as dynamin
(Caldieri et al., 2008), Tks5 (Seals et al., 2005), IQGAP1 (SakuraiYageta et al., 2008) and paxillin (Bowden et al., 1999). It is
possible that Src is activated before its localization with downstream
actin-associated substrates in pre-invadopodia. Once preinvadopodia assembly is complete, Src is inactivated [presumably
by C-terminal Src kinase (CSK) acting on pY527 (Okada et al.,
1991)] and released to regulate additional proteins involved in
actin dynamics and MMP delivery to invadopodia. In this way, Src
might act as a regulator of several sequentially coordinated proteininteraction events that direct the diverse array of cellular processes
at invadopodia, including actin assembly, membrane trafficking
and ECM degradation.
It is known that invadopodia produced by cancer cells and
transformed fibroblasts use similar signaling pathways and contain
many of the same proteins as podosomes produced by osteoclasts,
dendritic cells and macrophages (Linder, 2009). SRC-null
osteoclasts have been used to study the role of Src in podosome
assembly and dynamics (Destaing et al., 2008). WT Src and
Src527F were both able to restore normal podosome organization,
whereas Src295M did not. These data in podosomes support our
findings in invadopodia, but since this report did not address the
functionality of these cells to degrade ECM, it is not known
whether WT Src is needed for maturation in this system. These
results are particularly interesting because Src has been suggested
to act as a ‘molecular switch’ to regulate dynamin–Cbl signaling
complexes (Bruzzaniti et al., 2005) and as a protein with an
important (kinase independent) adaptor function (Bruzzaniti et al.,
2009) in osteoclast podosomes. Manipulation of Src activity in
WT osteoclasts also suggest a dual function for Src in the regulation
of actin dynamics through cortactin phosphorylation in podosome
assembly and subsequent maturation into more highly organized
structures known as sealing zones (Luxenburg et al., 2006).
We identify cortactin as a key regulator of invadopodia
maturation downstream of WT Src activity. We show that
constituitively active Src is sufficient to target cortactin to preinvadopodia (Fig. 3C, Fig. 4B), but cortactin is targeted independent
of its tyrosine phosphorylation (Fig. 6D,E). This is in agreement
with previous reports demonstrating that dephosphorylated cortactin
acts as a scaffold to recruit Arp2/3, N-WASp and cofilin (Oser et
al., 2009). Interestingly, cortactin phosphorylated at Tyr421 is
enriched in pre-invadopodia (SYF Src527F) and in matrixdegrading mature invadopodia (SYF+/+ Src527F) (Fig. 6A;
supplementary material Fig. S3A). In addition, tyrosine
phosphorylation of cortactin is required for invadopodia maturation
and ECM degradation (Fig. 6D,E) (Ayala et al., 2008; Desmarais
et al., 2009; Webb et al., 2007). These data suggest that

phosphorylation of cortactin occurs before ECM degradation.
However, in our SYF/SYF+/+ model this initial cortactin
phosphorylation is not sufficient to drive maturation in the absence
of WT Src, suggesting that cortactin must be dephosphorylated
before maturation can occur. Our proposed mechanism of dynamic
Src activity on cortactin phosphorylation in invadopodia maturation
is consistent with the model recently proposed by the Condeelis
laboratory (Oser et al., 2009), whereby cyclical cortactin
phosphorylation regulates actin polymerization and invadopodia
stabilization.
Here, we show that Src activation and inactivation regulates
cortactin phosphorylation during invadopodia maturation. Future
studies will be required to determine whether Src kinase is directly
responsible for the initial phosphorylation of cortactin to promote
invadopodia assembly or in subsequent step(s) to regulate
maturation (Huang et al., 1998). Fer (El Sayegh et al., 2005) and
Abl family kinases (Boyle et al., 2007) are also present in SYF
cells and might act downstream of Src to regulate one or more of
these steps. It also follows that tyrosine phosphatases are critically
important in the regulation of invadopodia maturation, because
cortactin and other possible targets downstream of Src kinase
activity in our system require dynamic cycles of phosphorylation
and dephosphorylation to drive ECM degradation. Protein tyrosine
phosphatase 1B is a good candidate for this process because it is
known to regulate Src in invadopodia dynamics (Cortesio et al.,
2008) and has subsequently been shown to regulate cortactin
dephosphorylation (Stuible et al., 2008). Nonetheless, we show
that WT Src kinase is the critical upstream regulator of other
downstream kinases and phosphatases important to these processes.
Invadopodia maturation is associated with the delivery of MMPs
to invadopodia sites (Artym et al., 2006; Clark et al., 2007). MT1MMP is cited as the key MMP that regulates ECM degradation at
invadopodia (Poincloux et al., 2009) and Src kinase activity is
known to regulate phosphorylation of MT1-MMP and proteins
associated with its trafficking to the cell membrane (Nyalendo et
al., 2008; Nyalendo et al., 2007). Future studies should address
whether WT Src is necessary to control trafficking to, or activation
of MT1-MMP at invadopodia. These studies are further warranted
because it has been proposed that a major role of cortactin in
invadopodia function involves the targeting and delivery of MMPs
to invadopodia to enhance ECM degradation (Clark and Weaver,
2008; Clark et al., 2007).
This report identifies a dominant oncogene that requires the
proto-oncogenic complement to reach its full spectrum of
transforming functionality. Unlike tumor suppressor proteins, which
often require loss of non-mutated alleles, little is known about the
potential effect of the presence or absence of proto-oncogenes on
their oncogenic counterparts during tumorigenesis. A function in
Ras-induced tumorigenesis has been described for Ras proto-
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oncogenes (Singh et al., 2005), where WT Ras has been reported
to regulate the functioning of oncogenic Ras with regards to cell
proliferation. Our results are consistent with those from the majority
of solid human tumors that contain elevated c-Src expression or
specific activity due to hyperactivation of upstream regulatory
pathways, rather than activating point mutations (Yeatman, 2004).
To our knowledge, this is the first description of such a finding.
Similar mechanisms might be required for other transforming
kinases involved in driving tumor progression.
Materials and Methods
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Cell culture

HNSCC cell lines UMSCC1, FADU and OSC19 were obtained from Jeffery Myers
(M. D. Anderson Cancer Center, Houston, TX). These lines along with UMSCC2
(Thomas Carey, University of Michigan, Ann Arbor, MI), 1483 (David Raben,
University of Colorado Denver, Aurora, CO) and MSK921 (Peter Sacks, New York
University, New York, NY) were cultured as previously described (Rothschild et al.,
2006). SYF (Src–/– Yes–/– Fyn–/–) and SYF+/+ (Src+/+ Yes–/– Fyn–/–) cells were obtained
from the American Type Culture Collection. Control non-silencing and human SRCtargeted siRNA (5⬘-AAACTCCCCTTGCTCATGTACTT-3⬘) were from Dharmacon.
OSC19 cells stably expressing vector control or SRC-targeted shRNA were created
by infection with control or human Src specific lentivirus (Santa Cruz) and cultured
according to the manufacturer’s instructions. SYF or SYF+/+ cells stably expressing
GFP-tagged human cortactin {WT or Y421F, Y466F, Y482F [triple point mutant
(TPM)]} were created using the Flp-InTM system (Invitrogen). These lines were
transfected with siRNA targeting murine cortactin (Cttn) (5⬘-GCTTCGAGAGAATGTCTTC-3⬘) (siCTTN, Dharmacon). For transient transfections, 3⫻106
cells were incubated with 2 g plasmid construct or siRNA. Fibroblast lines were
transfected with the Nucleofector I device (Amaxa Biosystems) and HNSCC lines
were transfected with TurboFectTM transfection reagent (Fermentas).
Immunofluorescence labeling and confocal microscopy

Cells were plated on FITC-gelatin (Sigma)-coated coverslips as described (Artym et
al., 2006) for 12–24 hours. Cells were fixed with fresh 4% formaldehyde and
permeabilized with 0.4% Triton X-100 in PBS. Primary antibodies were diluted with
5% BSA in PBS. Antibodies used were: cortactin 4F11, cortactin EP1922Y (Novus
Biologicals), human cort-pY421 (Ammer et al., 2009), Src-pY418 (Biosource), Src
GD11 (Upstate), GFP/Cerulean 3E6 (Invitrogen), pTyr-100 (BD Biosciences), Alexa
Fluor 405 goat anti-rabbit and Alexa Fluor 647 goat anti-mouse (Molecular Probes).
F-actin was labeled with Rhodamine-conjugated phalloidin (Molecular Probes).
Cells were mounted in Fluoromount-G (Southern Biotech) and imaged with a Zeiss
LSM510 confocal microscope using AIM software (Carl Zeiss MicroImaging). A
Nikon Swept-Field using Nikon Elements software (Nikon Instruments) was used
for imaging of Src–Cer.
Invadopodia and matrix-degradation assays

Cells with invadopodia were identified by the presence of at least one actin and
cortactin aggregate within the cell (n≥300). The number of invadopodia per cell was
calculated by counting the number of actin and cortactin aggregates within
invadopodia forming cells (n≥150). Degradation per cell area was analyzed using
ImageJ as described previously (Clark et al., 2007). Cells with invadopodia-degrading
matrix were identified by at least one actin and cortactin aggregate colocalizing with
a ‘dark hole’ that corresponded to degraded FITC-matrix (n≥50). Data were pooled
from several independent experiments; n represents the number of cells analyzed
within each experimental group.
Antibodies and western blotting

Western blotting of cell lysates was conducted as described (Rothschild et al., 2006).
The following antibodies were used: 4F11, Src clone GD11 (Upstate); -actin
(Calbiochem); Living Colors GFP clone JL-8 (BD); Cort-pY421, Src-pY418
(Biosource); avian Src clone EC10 (Millipore) and Yes, Fyn (Cell Signaling).
Plasmids

The Src–GFP linker constructs (WT, 527F, and 295M) were a gift from Margaret
Frame (The Beatson Institute for Cancer Research, Glasgow, UK). Substitution of
green fluorescent protein (GFP) with cerulean or mCherry fluorescent protein was
accomplished through digestion of Src–pEGFP-N1, pmCherry-C1, and mCeruleanC1 fluorescent vectors with AgeI and BrsGI. The resulting mCherry and mCerulean
fragments (~700 bp) were ligated into the GFP-digested Src-containing pEGFP-N1
vector (BD). Temperature-sensitive v-Src (tsLA29) was subcloned from pCMVtsLA29 vector into EGFP-N1 using unique EcoRI and BamHI restriction sites.
Human cortactin constructs.

A single-stranded primed cDNA library (Invitrogen) was used for cloning human
cortactin (CTTN) cDNA. The cDNA was PCR amplified to produce a 965 bp KpnI–
HincII fragment and a 688 bp HincII–EcoRI fragment. Fragments were ligated into
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pcDNA3FLAG2AB that had been digested with KpnI and EcoRI, to generate the
1653 bp full-length CTTN cDNA. The CTTN triple tyrosine mutant (TYM) was
generated using the QuikChange kit with primers designed to alter codons 421, 470
and 486 from tyrosine to phenylalanine and confirmed by DNA sequencing. WT and
TYM CTTN cDNAs were subsequently amplified as EcoRI–KpnI fragments and
subcloned into pEGFP-N1 (WT) or pAcGFP-N1 (TYM). GFP–CTTN WT and
TYM fragments were amplified by PCR and subcloned into pEF5/FRT/V5-D-TOPO
(Invitrogen) and stable SYF and SYF+/+ cell lines generated using the Flp-In system
(Invitrogen) according to the manufacturer’s instructions.
Immunoprecipitation

Cells were lysed in NP40 Buffer (20 mM HEPES-KOH, pH 7.8, 50 mM KCl, 1 mM
EDTA and 1% NP40). Anti-cortactin (4F11, 5 g) was incubated with 0.5 mg
clarified lysates for 2 hours at 4°C, then incubated with 40 l Protein A/G Beads
(Thermo Scientific) for 1 hour at 4°C. Immune complexes were collected by
centrifugation, washed twice with NP40 Buffer, separated by SDS-PAGE and western
blotted with antibodies as described.
SH2 and PTB binding assay

SH2 and PTB domain binding assays were performed as described (Dierck et al.,
2009; Machida et al., 2007). Briefly, SYF cell lysates were spotted in duplicate on
a nitrocellulose membrane in register with the wells of a 96-well chamber plate.
Each well was separately incubated with purified GST–SH2 or GST–PTB domains
(~100 nM) for 2 hours. Probe binding was detected by enhanced chemiluminescence
(ECL) (Perkin Elmer) and digitally captured (Kodak Image Station). Two independent
experiments were performed in duplicate, providing four quantifiable data points for
each probe. The array images were background-subtracted and the integrated density
of each spot was measured using ImageJ (v1.40).
Statistical analysis

Differences in mean values between groups were evaluated using a Student’s t-test
(two groups) or a one-way ANOVA (multiple groups) followed by Scheffe post-hoc
testing.
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